AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 265 filers reported holding AVANOS MED INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,836 | -20.9% | 437 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $11,170 | -14.1% | 437 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $12,996 | +9.9% | 437 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $11,825 | +18.2% | 437 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $10,000 | -16.7% | 437 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $12,000 | -20.0% | 437 | -2.0% | 0.00% | -50.0% |
| Q1 2022 | $15,000 | -11.8% | 446 | -10.1% | 0.00% | 0.0% |
| Q4 2021 | $17,000 | +13.3% | 496 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | -61.5% | 496 | -48.9% | 0.00% | 0.0% |
| Q2 2021 | $39,000 | +85.7% | 970 | +100.0% | 0.00% | -33.3% |
| Q1 2021 | $21,000 | +50.0% | 485 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $14,000 | +7.7% | 485 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $13,000 | -18.8% | 485 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $16,000 | -11.1% | 485 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $18,000 | -14.3% | 485 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $21,000 | – | 485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |